Lundbeck sues competitor for infringing on patent rights

Pharmaceutical firm Lundbeck has filed a lawsuit in the US against Viatris for violating the patent protection of schizophrenia drug Abilify Maintena, Bloomberg News reports.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Lundbeck preps for war against generic drugmakers in US
For subscribers
Novo Nordisk initiates patent suit to stop Ozempic copies
For subscribers
Genmab loses royalties case against Janssen
For subscribers